SCHEMBL8860437

SCHEMBL8860437

Fc1ccc(-c2c(-c3ccncc3)ncn2CCCN2CCCC2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 19/20 1.00
MAPK12 P53778 19/20 1.00
MAPK11 Q15759 19/20 1.00
MAPK14 Q16539 19/20 1.00
MAP4K4 O95819 1/20 0.70
MAPK9 P45984 1/20 0.70
CSNK1A1 P48729 1/20 0.70
CSNK1D P48730 1/20 0.70
CDC42BPA Q5VT25 1/20 0.70
AURKB Q96GD4 1/20 0.70
MAP4K5 Q9Y4K4 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906627 1.00 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAP4K4
SCHEMBL4918422 0.99 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAP4K4
SCHEMBL8860442 0.99 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAP4K4
Sb-210313 SCHEMBL4918397 0.90 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14
SCHEMBL8860270 0.90 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14
SCHEMBL4915601 0.87 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAP4K4
SCHEMBL4912942 0.84 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14MAP4K4
SCHEMBL4916399 0.83 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14MAP4K4
SCHEMBL4917040 0.83 MAPK14 (1.00) MAPK13MAPK12MAPK11MAPK14MAP4K4
SCHEMBL27311897 0.83 MAPK14 (0.78) MAPK13MAPK12MAPK11MAPK14MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5670527-A CYTOKINE INHIBITORS USEFUL IN TREATING ASTHMA, OSTEOPOROSIS, ARTHRITIS, INFLAMMATION, SEPSIS, CARDIOVASCULAR DISORDERS, DIABETES, MULTIPLE SCLEROSIS, SKIN DISORDERS SMITHKLINE BEECHAM CORPORATION (US) 1997-09-23 US disclosed